Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study

René S. Kahn, S. Charles Schulz, Veselin D. Palazov, Efren B. Reyes, Martin Brecher, Ola Svensson, Henrik M. Andersson, Didier Meulien

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences